Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart...

Area of Science:

• Cardiology
• Pharmacology
• Physiology

Background:

• Chronic heart failure (CHF) involves complex neurohormonal dysregulation.
• Endothelin (ET) receptors, particularly ET-A and ET-B, play a role in cardiovascular pathophysiology.
• Targeting ET receptors is a potential therapeutic strategy for heart failure.

Purpose of the Study:

• To compare the hemodynamic effects of selective endothelin (ET)-A receptor blockade versus dual ET-A/B receptor blockade in patients with chronic heart failure.
• To investigate differential responses to specific ET receptor antagonists.

Main Methods:

• A randomized, placebo-controlled, three-way crossover study involving nine patients with chronic heart failure (NYHA class II-III).
• Intravenous infusions of BQ-123 (selective ET-A blockade) and combined BQ-123 and BQ-788 (dual ET-A/B blockade) were administered.
• Hemodynamic parameters including cardiac output, mean arterial pressure, systemic vascular resistance, and pulmonary pressures were measured.

Main Results:

• Selective ET-A blockade significantly increased cardiac output and reduced systemic vascular resistance and mean arterial pressure.
• Dual ET-A/B blockade resulted in less pronounced changes in systemic hemodynamics compared to selective ET-A blockade.
• Both blockade strategies similarly reduced pulmonary artery pressure and pulmonary vascular resistance.
• Dual ET-A/B blockade increased plasma ET-1 concentrations, unlike selective ET-A blockade.

Conclusions:

• Selective ET-A blockade promotes greater systemic vasodilation and does not impact ET-1 clearance.
• Dual ET-A/B blockade offers comparable pulmonary pressure reduction but distinct systemic hemodynamic effects.
• Significant hemodynamic differences exist between selective ET-A and dual ET-A/B blockade, potentially influencing individual patient responses in chronic heart failure.